Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant (OCTCAV)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Tamim Nazif, Columbia University
ClinicalTrials.gov Identifier:
NCT01403142
First received: July 25, 2011
Last updated: April 20, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2022
  Estimated Primary Completion Date: July 2021 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):